DOV
FY2026 Q2 · Calendar Q3 2026
Dover Corporation
Dover's Q2 results encapsulate a crosscurrent story: secular demand is accelerating across data-center liquid cooling, CO2 refrigeration, aerospace, space, and biopharma, now representing approximately 25% of revenue. The order book is healthy with book-to-bill at 1.06 across all five segments, and management raised full-year adjusted EPS guidance. Yet the stock fell roughly 8% on the print. The disconnect centers on near-term execution: a refrigeration facility consolidation caused throughput shortfalls that cost an estimated 1 to 1.5% of organic growth and pressured margins, and revenue missed consensus. Investors must weigh whether the guidance raise already prices in a clean H2 recovery or whether execution risk in refrigeration and the heat-exchanger capacity ramp could persist. The prior quarter set a high bar with double-digit revenue growth and 24% bookings growth; Q2's 7%…
EPS surprise+0.7%
Market move-7.8%
